Stoke Therapeutics CEO Edward Kaye's 2023 pay falls 39% to $3.5M
Stoke Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 23, 2024
Stoke Therapeutics reported fiscal year 2023 executive compensation information on April 23, 2024.
In 2023, three executives at Stoke Therapeutics received on average a compensation package of $2.3M, a 35% decrease compared to previous year.
Average pay of disclosed executives at Stoke Therapeutics
Edward M. Kaye, Chief Executive Officer, received $3.5M in total, which decreased by 39% compared to 2022. 37% of Kaye's compensation, or $1.3M, was in stock awards. Kaye also received $310K in non-equity incentive plan, $1.3M in option awards, $626K in salary, as well as $13K in other compensation.
Barry S. Ticho, Chief Medical Officer, received a compensation package of $1.6M, which decreased by 31% compared to previous year. 30% of the compensation package, or $494K, was in salary.
Stephen J. Tulipano, Chief Financial Officer, earned $1.6M in 2023, a 31% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 23, 2024.